Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 156, Issue -, Pages 43-52Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2018.06.055
Keywords
Pyrazolo[3,4-d]pyrimidin-4(5H)-one; 1,2,3-Triazole; Glioma; Anti-cancer activity; Apoptosis
Categories
Funding
- UGC-UPE/FAR/OU/2017 [63]
- UGC, New Delhi
Ask authors/readers for more resources
A series of hybrid aza heterocycles containing pyrazolo[3,4-d]pyrimidin-4(5H)-ones tethered to 1,2,3triazole scaffold were synthesized from 1,3-dipolar cycloaddition reaction of pyrazolopyrimidinone based alkyne with azides using Cu(II) catalyst in presence of sodium ascorbate and evaluated for their anticancer efficacy in vitro against C6 rat and U87 human glioma cell lines. These compounds induced a concentration dependent inhibition of C6 rat and U87 human glioma cell proliferation. Compound 5f arrested the cells at S-phase of the cell cycle and induced apoptosis in U87 GBM cell lines. Further, apoptosis was evidenced by the cleavage of Caspase-3, PARP and up regulation of p53. In silico docking studies reveal that the compounds 5a, 5f and 51 were more effective in binding with TGFBR2 than other compounds. (C) 2018 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available